Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma

Background & Aims: The combination of locoregional therapies (LRT) with immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC) is expected to enhance immune-mediated anti-tumor effects. Although clinical trials are underway, an unmet need exists to understand the immu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Robin Schmidt, Bernhard Gebauer, Nilufar Akbari, Christoph Roderburg, Giovanni Federico Torsello, Uli Fehrenbach, Timo Alexander Auer, Raphael Mohr, Gracia Lana Ardila Pardo, Winna Lim, Fabio Pivetta, Elif Can, Charlie Alexander Hamm, Frank Tacke, Bernd Hamm, Linda Hammerich, Lynn Jeanette Savic
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-12-01
coleção:	JHEP Reports
Assuntos:	Locoregional therapies Transarterial chemoembolization Flow cytometry Immune phenotyping Immune response
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2589555925002344
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!